Department of Anesthesiology, Montefiore Medical Center, Bronx, New York, USA.
Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA.
Pharmacoepidemiol Drug Saf. 2024 Apr;33(4):e5788. doi: 10.1002/pds.5788.
To evaluate the validity of ICD-10-CM code-based algorithms as proxies for influenza in inpatient and outpatient settings in the USA.
Administrative claims data (2015-2018) from the largest commercial insurer in New Jersey (NJ), USA, were probabilistically linked to outpatient and inpatient electronic health record (EHR) data containing influenza test results from a large NJ health system. The primary claims-based algorithms defined influenza as presence of an ICD-10-CM code for influenza, stratified by setting (inpatient/outpatient) and code position for inpatient encounters. Test characteristics and 95% confidence intervals (CIs) were calculated using test-positive influenza as a reference standard. Test characteristics of alternative outpatient algorithms incorporating CPT/HCPCS testing codes and anti-influenza medication pharmacy claims were also calculated.
There were 430 documented influenza test results within the study period (295 inpatient, 135 outpatient). The claims-based influenza definition had a sensitivity of 84.9% (95% CI 72.9%-92.1%), specificity of 96.3% (95% CI 93.1%-98.0%), and PPV of 83.3% (95% CI 71.3%-91.0%) in the inpatient setting, and a sensitivity of 76.7% (95% CI 59.1%-88.2%), specificity of 96.2% (95% CI 90.6%-98.5%), PPV of 85.2% (95% CI 67.5%-94.1%) in the outpatient setting. Primary inpatient discharge diagnoses had a sensitivity of 54.7% (95% CI 41.5%-67.3%), specificity of 99.6% (95% CI 97.7%-99.9%), and PPV of 96.7% (95% CI 83.3%-99.4%). CPT/HCPCS codes and anti-influenza medication claims were present for few outpatient encounters (sensitivity 3%-10%).
In a large US healthcare system, inpatient ICD-10-CM codes for influenza, particularly primary inpatient diagnoses, had high predictive value for test-positive influenza. Outpatient ICD-10-CM codes were moderately predictive of test-positive influenza.
评估基于 ICD-10-CM 代码的算法在美国住院和门诊环境中作为流感替代指标的有效性。
使用来自美国新泽西州(NJ)最大商业保险公司的行政索赔数据(2015-2018 年),对门诊和住院电子健康记录(EHR)数据进行概率链接,这些数据包含来自 NJ 大型卫生系统的流感检测结果。主要基于索赔的算法将门诊和住院环境中存在流感的 ICD-10-CM 代码定义为流感,并按代码位置进行分层。使用阳性流感检测作为参考标准计算测试特征和 95%置信区间(CI)。还计算了包含 CPT/HCPCS 检测代码和抗流感药物药房索赔的替代门诊算法的测试特征。
在研究期间,共记录了 430 份流感检测结果(295 份住院,135 份门诊)。基于索赔的流感定义在住院环境中的敏感性为 84.9%(95%CI 72.9%-92.1%),特异性为 96.3%(95%CI 93.1%-98.0%),PPV 为 83.3%(95%CI 71.3%-91.0%),在门诊环境中的敏感性为 76.7%(95%CI 59.1%-88.2%),特异性为 96.2%(95%CI 90.6%-98.5%),PPV 为 85.2%(95%CI 67.5%-94.1%)。主要的住院出院诊断的敏感性为 54.7%(95%CI 41.5%-67.3%),特异性为 99.6%(95%CI 97.7%-99.9%),PPV 为 96.7%(95%CI 83.3%-99.4%)。很少有门诊就诊者有 CPT/HCPCS 代码和抗流感药物的索赔(敏感性 3%-10%)。
在大型美国医疗保健系统中,住院 ICD-10-CM 代码的流感,特别是主要的住院诊断,对阳性流感检测具有较高的预测价值。门诊 ICD-10-CM 代码对阳性流感检测具有中等预测价值。